Vosoritide
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
Healthcare and Psychosocial Needs in Achondroplasia Across the Lifespan: Developmental Functioning, Multidisciplinary Care, and Family-Centered Outcomes.
Journal: Healthcare (Basel, Switzerland)
Published: July 22, 2026
From FGFR3 Hyperactivation to Disease-Modifying Therapy in Pediatric Achondroplasia: Molecular Mechanisms, Clinical Evidence, and Emerging Treatments.
Journal: Children (Basel, Switzerland)
Published: July 22, 2026
Slipped Capital Femoral Epiphysis during Vosoritide Therapy for Short Stature: A Case Series.
Journal: Hormone research in paediatrics
Published: June 14, 2026
Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.
Journal: Basic research in cardiology
Published: April 27, 2026
Perceived Impact of Vosoritide on Health-Related Quality of Life in Children with Selected Genetic Causes of Short Stature: A Qualitative Study of Children and Caregivers.
Journal: Hormone research in paediatrics
Published: April 27, 2026
Real-world growth outcomes and safety of vosoritide in children with achondroplasia: a Brazilian single center 24 monhts experience.
Journal: Hormone research in paediatrics
Published: April 22, 2026
Navepegritide in children with achondroplasia.
Journal: Translational pediatrics
Published: April 13, 2026
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.
Journal: Therapeutic advances in endocrinology and metabolism
Published: March 19, 2026
Development of Muscle Function in Children with Achondroplasia Under Vosoritide Treatment: A Retrospective Single-Centre Observational Study.
Journal: Journal of musculoskeletal & neuronal interactions
Published: March 01, 2026
Real-World Evidence on the Effectiveness and Safety of Vosoritide in Latin American Patients With Achondroplasia (EVOLAC).
Journal: American journal of medical genetics. Part A
Published: February 27, 2026
Update and review of treatment in achondroplasia.
Journal: Anales de pediatria
Published: February 23, 2026
Last Updated: 09/26/2026